Key Findings

The study evaluates the use of boronic acid as an inhibitor to enhance the detection of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella spp. and Escherichia coli, particularly in cases where ESBLs may be masked by plasmid-mediated AmpC beta-lactamases (pAmpCs).